{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:38:36Z","timestamp":1784864316009,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000382","name":"Society for Endocrinology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG-05-008"],"award-info":[{"award-number":["RG-05-008"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["BHF RE\/08\/001"],"award-info":[{"award-number":["BHF RE\/08\/001"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejphar.2022.175111","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T01:27:48Z","timestamp":1655688468000},"page":"175111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Comparison of mechanisms of angiostasis caused by the anti-inflammatory steroid 5\u03b1-tetrahydrocorticosterone versus conventional glucocorticoids"],"prefix":"10.1016","volume":"929","author":[{"given":"Amber J.","family":"Abernethie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Gastaldello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Maltese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1117-2273","authenticated-orcid":false,"given":"Ruth A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry J.","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2416-1648","authenticated-orcid":false,"given":"Brian R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0730-4803","authenticated-orcid":false,"given":"Dawn EW.","family":"Livingstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick WF.","family":"Hadoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6916-2994","authenticated-orcid":false,"given":"Ruth","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.175111_bib1","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1042\/BST0341018","article-title":"Dual-specificity phosphatase 1: a critical regulator of innate immune responses","volume":"34","author":"Abraham","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejphar.2022.175111_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nprot.2011.435","article-title":"Use of the mouse aortic ring assay to study angiogenesis","volume":"7","author":"Baker","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2022.175111_bib3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/endo.133.2.8344212","article-title":"The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors","volume":"133","author":"Beck","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2022.175111_bib4","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.90.10.4441","article-title":"The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways","volume":"90","author":"Beck","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2022.175111_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.steroids.2014.04.005","article-title":"Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease","volume":"91","author":"Bene","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.ejphar.2022.175111_bib6","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1002\/art.20583","article-title":"Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action","volume":"50","author":"Buttgereit","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2022.175111_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MED.0b013e32835430bf","article-title":"The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome","volume":"19","author":"Castinetti","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.ejphar.2022.175111_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/928315","article-title":"Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling","author":"Chen","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2022.175111_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9726503","article-title":"Heme oxygenase-1 promotes delayed wound healing in diabetic rats","volume":"2016","author":"Chen","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2022.175111_bib10","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/humrep\/dep099","article-title":"Mifepristone acts as progesterone antagonist of non-genomic responses but inhibits phytohemagglutinin-induced proliferation in human T cells","volume":"24","author":"Chien","year":"2009","journal-title":"Hum. Reprod. (Oxf.)"},{"key":"10.1016\/j.ejphar.2022.175111_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2011.12.004","article-title":"Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor","volume":"134","author":"Clark","year":"2012","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2022.175111_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tips.2015.09.002","article-title":"Activation of the glucocorticoid receptor in acute inflammation: the SEDIGRAM concept","volume":"37","author":"De Bosscher","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2022.175111_bib13","doi-asserted-by":"crossref","first-page":"15827","DOI":"10.1073\/pnas.0505554102","article-title":"A fully dissociated compound of plant origin for inflammatory gene repression","volume":"102","author":"De Bosscher","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2022.175111_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vph.2016.10.004","article-title":"Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor","volume":"89","author":"Drebert","year":"2017","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175111_bib15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0031-6997(24)01468-6","article-title":"Multiple actions of steroid hormones--a focus on rapid, nongenomic effects","volume":"52","author":"Falkenstein","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2022.175111_bib16","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2022.175111_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00000658-198709000-00016","article-title":"Angiostatic steroids. Method of discovery and mechanism of action","volume":"206","author":"Folkman","year":"1987","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejphar.2022.175111_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","article-title":"Regulation of the inflammatory response in cardiac repair","volume":"110","author":"Frangogiannis","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2022.175111_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bcp.2017.01.008","article-title":"Safer topical treatment for inflammation using 5alpha-tetrahydrocorticosterone in mouse models","volume":"129","author":"Gastaldello","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175111_bib20","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.4049\/jimmunol.181.8.5711","article-title":"The angiogenic response of the aorta to injury and inflammatory cytokines requires macrophages","volume":"181","author":"Gelati","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2022.175111_bib21","doi-asserted-by":"crossref","unstructured":"Guo, F., Si, C., Zhou, M., et al., 2018. Decreased PECAM1-mediated TGF-\u03b21 expression in the mid-secretory endometrium in women with recurrent implantation failure. Hum. Reprod. (Oxf.) 33, 832-843.","DOI":"10.1093\/humrep\/dey022"},{"key":"10.1016\/j.ejphar.2022.175111_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.yfrne.2007.10.004","article-title":"The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings","volume":"29","author":"Haller","year":"2008","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2022.175111_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.SMJ.0000051146.93190.4A","article-title":"Selective estrogen receptor modulators","volume":"96","author":"Haskell","year":"2003","journal-title":"South. Med. J."},{"key":"10.1016\/j.ejphar.2022.175111_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0955-0674(03)00100-5","article-title":"PECAM-1: old friend, new partners","volume":"15","author":"Ilan","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejphar.2022.175111_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1172\/JCI200111374","article-title":"A complex role for the progesterone receptor in the response to vascular injury","volume":"108","author":"Karas","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2022.175111_bib26","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.2741\/2853","article-title":"The role of chemokines in neutrophil biology","volume":"13","author":"Kobayashi","year":"2008","journal-title":"Front. Biosci. : J. Vis. Literacy"},{"key":"10.1016\/j.ejphar.2022.175111_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1210\/me.2005-0165","article-title":"Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues","volume":"20","author":"Koyanagi","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2022.175111_bib28","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.4049\/jimmunol.177.11.7497","article-title":"DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response","volume":"177","author":"Lang","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2022.175111_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00424-012-1155-2","article-title":"Non-genomic effect of glucocorticoids on cardiovascular system","volume":"464","author":"Lee","year":"2012","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2022.175111_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MOH.0000000000000239","article-title":"Endothelial functions of platelet\/endothelial cell adhesion molecule-1 (CD31)","volume":"23","author":"Lertkiatmongkol","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ejphar.2022.175111_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014476","article-title":"Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration","volume":"5","author":"Logie","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.175111_bib32","article-title":"Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration","volume":"5","author":"Logie","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.175111_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0039-128X(01)00133-7","article-title":"Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions","volume":"67","author":"Lonard","year":"2002","journal-title":"Steroids"},{"key":"10.1016\/j.ejphar.2022.175111_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/cvr\/cvq149","article-title":"Improved heart function follows enhanced inflammatory cell recruitment and angiogenesis in 11betaHSD1-deficient mice post-MI","volume":"88","author":"McSweeney","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2022.175111_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ando.2018.03.004","article-title":"Glucocorticoid receptor modulators","volume":"79","author":"Meijer","year":"2018","journal-title":"Ann. Endocrinol."},{"key":"10.1016\/j.ejphar.2022.175111_bib36","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.ymthe.2018.05.002","article-title":"MicroRNA-148b targets the TGF-beta pathway to regulate angiogenesis and endothelial-to-mesenchymal transition during skin wound healing","volume":"26","author":"Miscianinov","year":"2018","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.ejphar.2022.175111_bib37","first-page":"1","article-title":"Genomic and non-genomic effects of glucocorticoids: implications for breast cancer","volume":"8","author":"Mitre-Aguilar","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2022.175111_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192746","article-title":"Species-specific regulation of angiogenesis by glucocorticoids reveals contrasting effects on inflammatory and angiogenic pathways","volume":"13","author":"Morgan","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.175111_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/JOE-16-0501","article-title":"11\u03b2-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI","volume":"233","author":"Mylonas","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2022.175111_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1507\/endocrj.52.245","article-title":"Progesterone receptor subtypes in vascular smooth muscle cells of human aorta","volume":"52","author":"Nakamura","year":"2005","journal-title":"Endocr. J."},{"key":"10.1016\/j.ejphar.2022.175111_bib41","doi-asserted-by":"crossref","unstructured":"Neubauer, K., Lindhorst, A., Tron, K., et al., 2008. Decrease of PECAM-1-gene-expression induced by proinflammatory cytokines IFN-gamma and IFN-alpha is reversed by TGF-beta in sinusoidal endothelial cells and hepatic mononuclear phagocytes. BMC Physiol. 8, 9.","DOI":"10.1186\/1472-6793-8-9"},{"key":"10.1016\/j.ejphar.2022.175111_bib42","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1007\/s12325-017-0621-9","article-title":"Effects of ketoconazole on the pharmacokinetics of mifepristone, a competitive glucocorticoid receptor antagonist, in healthy men","volume":"34","author":"Nguyen","year":"2017","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejphar.2022.175111_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","article-title":"Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment","volume":"186","author":"Patel","year":"2018","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2022.175111_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/187153012799279045","article-title":"Glucocorticoid analogues: potential therapeutic alternatives for treating inflammatory muscle diseases","volume":"12","author":"Reeves","year":"2012","journal-title":"Endocr. Metab. Immune Disord. - Drug Targets"},{"key":"10.1016\/j.ejphar.2022.175111_bib45","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1111\/j.1582-4934.2009.00810.x","article-title":"Immune cells and angiogenesis","volume":"13","author":"Ribatti","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2022.175111_bib46","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1359\/JBMR.050102","article-title":"Reduced expression of platelet endothelial cell adhesion molecule-1 in bone marrow cells in mice after skeletal unloading","volume":"20","author":"Sakuma-Zenke","year":"2005","journal-title":"J. Bone Miner. Res. : the official journal of the American Society for Bone and Mineral Research"},{"key":"10.1016\/j.ejphar.2022.175111_bib47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1600-0625.2006.00453.x","article-title":"Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index","volume":"15","author":"Schacke","year":"2006","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejphar.2022.175111_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.0300372101","article-title":"Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects","volume":"101","author":"Schacke","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2022.175111_bib49","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.0500641102","article-title":"Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis","volume":"102","author":"Small","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2022.175111_bib50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0002-9440(10)63890-4","article-title":"Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis","volume":"162","author":"Solowiej","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2022.175111_bib51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mce.2005.11.012","article-title":"Non-genomic glucocorticoid effects to provide the basis for new drug developments","volume":"246","author":"Song","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2022.175111_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mce.2007.05.019","article-title":"Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists","volume":"275","author":"Stahn","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2022.175111_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mce.2013.01.026","article-title":"Optimized glucocorticoid therapy: teaching old drugs new tricks","volume":"380","author":"Strehl","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2022.175111_bib54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/09513590.2013.856410","article-title":"Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties","volume":"30","author":"Sun","year":"2014","journal-title":"Gynecol. Endocrinol. : the official journal of the International Society of Gynecological Endocrinology"},{"key":"10.1016\/j.ejphar.2022.175111_bib55","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1210\/en.2006-0981","article-title":"Minireview: rapid glucocorticoid signaling via membrane-associated receptors","volume":"147","author":"Tasker","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2022.175111_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/WCO.0b013e32834232c6","article-title":"Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease","volume":"24","author":"Vahedi","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ejphar.2022.175111_bib57","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1530\/rep.1.00625","article-title":"The role of progesterone in endometrial angiogenesis in pregnant and ovariectomised mice","volume":"129","author":"Walter","year":"2005","journal-title":"Reproduction"},{"key":"10.1016\/j.ejphar.2022.175111_bib58","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/ATVBAHA.107.151456","article-title":"PECAM-1: a multi-functional molecule in inflammation and vascular biology","volume":"27","author":"Woodfin","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2022.175111_bib59","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1476-5381.2011.01465.x","article-title":"5alpha-reduced glucocorticoids exhibit dissociated anti-inflammatory and metabolic effects","volume":"164","author":"Yang","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175111_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12362","article-title":"Progesterone-mediated angiogenic activity of endothelial progenitor cell and angiogenesis in traumatic brain injury rats were antagonized by progesterone receptor antagonist","volume":"50","author":"Yu","year":"2017","journal-title":"Cell Prolif"},{"key":"10.1016\/j.ejphar.2022.175111_bib61","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.steroids.2007.03.012","article-title":"The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values","volume":"72","author":"Zhang","year":"2007","journal-title":"Steroids"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922003727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922003727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:57:47Z","timestamp":1777402667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922003727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":61,"alternative-id":["S0014299922003727"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175111","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of mechanisms of angiostasis caused by the anti-inflammatory steroid 5\u03b1-tetrahydrocorticosterone versus conventional glucocorticoids","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"175111"}}